Latest News for: receptor modulator

Edit

Selective Estrogen Receptor Modulators Market Research 2025-2030: Leading Players Shaping the Future of Selective Estrogen ...

Nasdaq Globe Newswire 09 Jun 2025
Selective estrogen receptor modulators are advancing notably in treating hormone‐driven conditions, offering opportunities across oncology ...
Edit

Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)

Pharmiweb 07 May 2025
... mocravimod, a novel oral sphingosine 1 phosphate (S1P) receptor modulator, to treat hematologic malignancies, today announced the appointment of Jens Hasskarl, MD, PhD, as Chief Medical Officer (CMO).
  • 1

Article Search

tools
×
×
×
×